The Tisch Cancer Institute (TCI), an NCI-Designated Cancer Center, and the Department of Oncological Sciences of the Icahn School of Medicine at Mount Sinai are seeking exceptional candidates (PhD, MD, or MD/PhD) of the highest caliber for faculty positions focused on cancer research, whose work—as consistent with our mission—will lead to advances in cancer prevention, prognosis, and therapy. Investigators with a focus in the areas of cancer epigenetics, genetics, metabolism, tumor microenvironment and targeted therapies are highly encouraged to apply. Investigators who are developing state-of-the-art technologies in data science, proteomics, single cell profiling, computational biology and model systems, are also of great interest to our mission.
Successful candidates will be expected to develop or expand independently funded research. New recruits will augment an intellectually vibrant and growing group of full-time faculty, with exceptional mentoring for all junior faculty.
Individuals underrepresented in science have additional opportunities through the Mount Sinai Laureates Program (https://icahn.mssm.edu/research/laureates/recruitment) which seeks to increase the diversity of our research faculty and support their growth as investigators and development towards leadership roles. We are highly committed to this purpose within our cancer center.
The TCI offers highly competitive start-up packages, salaries and benefits. Interested candidates are invited to submit the following documents in one PDF file to TCI-Recruitment@mssm.edu by April 15, 2021:
The Tisch Cancer Institute and the Icahn School of Medicine at Mount Sinai are committed to promoting and supporting diversity and inclusion throughout our research, clinical, and educational realms among students, faculty, and staff, and in the communities we serve. (https://icahn.mssm.edu/about/diversity)
PhD, MD, or MD/PhD
Internal Number: TCI20212
About The Tisch Cancer Institute at Mount Sinai
The Tisch Cancer Institute at Mount Sinai is a vital component of the Icahn School of Medicine at Mount Sinai and part of the Mount Sinai Health System. An NCI-Designated Cancer Center since 2015, it has distinct research programs in Cancer Immunology, Cancer Mechanisms, Cancer Prevention and Control, and Cancer Clinical Investigation (including a robust infrastructure for clinical trials and an Early Phase Trials Unit). It supports current shared resources in Flow Cytometry, Mouse Genetics, Microscopy, Biostatistics, and a Human Immune Monitoring Center.
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn... School of Medicine as one of the Top 20 Best Medical Schools in the country.
Mount Sinai embraces the principles of diversity and inclusion as key drivers for excellence and innovation for unrivaled healthcare service delivery, medical and health education, and research.